$28.90
+0.90 (+3.21%)
Open$27.71
Previous Close$28.00
Day High$28.90
Day Low$26.51
52W High$29.60
52W Low$5.90
Volume—
Avg Volume82.4K
Market Cap321.63M
P/E Ratio—
EPS$-19.76
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
-72.5% upside
Current
$28.90
$28.90
Target
$7.94
$7.94
$5.53
$7.94 avg
$9.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 41.73M | 55.50M | 49.01M |
| Net Income | -248,939,901 | -3,521,463 | -2,802,997 |
| Profit Margin | -596.6% | -6.3% | -5.7% |
| EBITDA | -170,041,161 | -5,026,082 | -4,562,575 |
| Free Cash Flow | — | -3,518,270 | -4,055,082 |
| Rev Growth | — | +7.8% | +7.4% |
| Debt/Equity | — | 0.88 | 0.82 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |